StockData
Accendra Health Inc logo

Accendra Health Inc (ACH) stock

ACHNYSEWholesale-Medical, Dental & Hospital Equipment & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026Score 4/3098% below fair value
$0.25+0.02 (+9.10%)

Close on Oct 30, 2026Market cap $19.55MP/E –Yield –

Earnings

Accendra Health's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Oct 29, 2026
Q3 FY2026 · estimated, after the close
Revenue, Q2 FY2026
$613.20M
Adj. (loss) income from continuing operations, net of tax, per common share, Non-GAAP, Q2 FY2026
-$0.19
Latest guidance
Lowered
Aug 10, 2026 · 2 items

Quarterly results

Revenue and earnings per share from each of Accendra Health's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q3 FY2026ended Sep 30, 2026Oct 29, 2026Expected–––––
Q2 FY2026ended Jun 30, 2026Aug 10, 2026before the open$613.20M–-$1.16-$0.19Release
Q1 FY2026ended Mar 31, 2026May 11, 2026before the open––––Release
Q4 FY2025ended Dec 31, 2025Feb 19, 2026after the close––––Release
Q3 FY2025ended Sep 30, 2025Oct 30, 2025after the close––––Release
Q2 FY2025ended Jun 30, 2025Aug 11, 2025before the open––––Release
Q1 FY2025ended Mar 31, 2025May 8, 2025before the open––––Release
Q4 FY2024ended Dec 31, 2024Feb 28, 2025before the open––––Release
Q3 FY2024ended Sep 30, 2024Nov 4, 2024before the open––––Release
Q2 FY2024ended Jun 30, 2024Aug 2, 2024before the open$2.70B+5.5%-$0.42$0.36Release
Q1 FY2024ended Mar 31, 2024May 3, 2024before the open$2.60B+4.0%-$0.29$0.19Release
Q4 FY2023ended Dec 31, 2023Feb 20, 2024before the open––––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Accendra Health's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
RevenueFY2026$2.45B – $2.55B$2.55B – $2.65BLoweredAug 10, 2026
Adjusted EBITDAnon-GAAPFY2026$300.00M – $320.00M$335.00M – $355.00MLoweredAug 10, 2026
Free cash flownon-GAAPFY2026$90.00M – $110.00M–NewFeb 19, 2026

Guidance history

Every forecast Accendra Health put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Aug 10, 2026Adjusted EBITDAFY2026$300.00M – $320.00MLowered
Aug 10, 2026RevenueFY2026$2.45B – $2.55BLowered
Feb 19, 2026Adjusted EBITDAFY2026$335.00M – $355.00MNew
Feb 19, 2026Free cash flowFY2026$90.00M – $110.00MNew
Feb 19, 2026RevenueFY2026$2.55B – $2.65BNew
Oct 30, 2025Adjusted EBITDAFY2025$376.00M – $382.00MNew
Oct 30, 2025Adjusted EPSFY2025$1.02 – $1.07New
Oct 30, 2025RevenueFY2025$2.76B – $2.82BNew
May 8, 2025Adjusted EBITDAFY2025$560.00M – $590.00MReaffirmed
May 8, 2025Adjusted EPSFY2025$1.60 – $1.85Reaffirmed
May 8, 2025RevenueFY2025$10.85B – $11.15BReaffirmed
Feb 28, 2025Capital expenditures, grossFY2025$250.00M – $270.00MNew
Feb 28, 2025Adjusted EBITDAFY2025$560.00M – $590.00MNew
Feb 28, 2025Adjusted EPSFY2025$1.60 – $1.85New
Feb 28, 2025Gross marginFY202520.75% – 21.25%New
Feb 28, 2025Interest expenseFY2025$138.00M – $142.00MNew
Feb 28, 2025Diluted weighted average sharesFY202580New
Feb 28, 2025Adjusted effective tax rateFY202529% – 30%New
Feb 28, 2025RevenueFY2025$10.85B – $11.15BNew
Nov 4, 2024Capital expendituresFY2024$225.00M – $235.00MNarrowed

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Accendra Health filed with the SEC as exhibits to Form 8-K or 6-K

  1. Accendra Health Receives Continued Listing Standard Notice from NYSE Regarding Market Capitalization and Stockholders’ Equity;
    Update
  2. Accendra Health Receives Continued Listing Standard Notice from NYSE;
    Update
  3. Accendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company’s Next Chapter of Growth
    Update
  4. Updates on Capital Allocation and CEO Succession Timing Plans
    Update
  5. Announces Adoption of Tax Asset Preservation Plan
    Update
  6. Reports Second Quarter 2026 Financial Results
    Results
  7. Second Quarter 2026 Continuing Operations Supplemental Slides August 10, 2026
    Results
  8. Health’s Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search
    Update
  9. Accendra Health Announces Expiration and Final Results of Offers and Consent Solicitations
    News
  10. Accendra Health Announces Early Results of Offers and Consent Solicitations
    News
  11. Accendra Health Announces Offers and Consent Solicitations
    Update
  12. SUBJECT TO EXECUTED NDA | CONFIDENTIAL Con | fid CO en NT tia AINS l |
    Update
  13. Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Transaction
    Results
  14. First Quarter 2026 Continuing Operations
    Results
  15. Accendra Health Reports Fourth Quarter 2025 Financial Results
    Results